Brain Stimulation and Aphasia Treatment



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:25 - 80
Updated:2/24/2018
Start Date:April 2012
End Date:April 2018
Contact:Astrid Fridriksson, M.A, CCC-SLP
Email:fridrika@mailbox.sc.edu
Phone:803-777-2693

Use our guide to learn which trials are right for you!

Transcranial Direct Current Stimulation and Aphasia Treatment Outcomes

The purpose of this study is to assess the changes in language processing of patients with
chronic, post-stroke aphasia following the application of brain stimulation. The brain
stimulation the investigators administer is called transcranial direct current stimulation
(tDCS). It involves passing a weak electrical current through the brain between two
electrodes in the form of damp sponges. One sponge will be placed over a specified area on
the damaged left hemisphere, while the other sponge will be placed on the right scalp.
Computer-controlled speech-language treatment will be administered during the application of
tDCS.

Stroke is the leading cause of adult disability in the United States. Approximately one-third
of all strokes result in acute language impairment (aphasia), with approximately one-fifth
suffering from chronic aphasia. Unfortunately, the prognosis for moderate to severe chronic
aphasia remains grim, as current behavioral treatment approaches usually offer only
limited-to-modest benefit. Recent advancements in understanding the relationship between low
current electrical brain stimulation and cortical plasticity suggest that the effect of
behavioral aphasia treatment could possibly be enhanced using anodal transcranial direct
current stimulation (A-tDCS). Indeed, we have shown how A-tDCS can significantly boost the
effect of behavioral aphasia treatment. Based on these results as well as our other studies
aimed at understanding how favorable brain plasticity correlates with positive treatment
outcome in aphasia, we propose to conduct a Phase II clinical trial utilizing a futility
design. Consistent with the goals of Program Announcement PAR-08-204 by the National
Institute on Deafness and Other Communication Disorders (NIDCD), we plan to "evaluate whether
there is sufficient evidence of short term improvement in humans to justify a phase III
trial."

Inclusion Criteria:

1. Patients must be willing and able to give informed consent.

2. Patients must be willing and able to comply with study requirements.

3. Patients must be between 25- and 80-years of age.

4. Patients must be native English speakers.

5. Patients must be pre-morbidly right-handed.

6. Patients must have sustained a one-time ischemic stroke in the left-hemisphere.

7. Patients must be greater than 6-months post-stroke.

8. Patients must have an aphasia diagnosis as confirmed by the Western Aphasia
Battery-Revised.

9. Patients must be MRI-compatible (e.g., no metal implants, not claustrophobic, etc.).

10. Patients must achieve at least 65% accuracy on naming task during screening -

Exclusion Criteria:

1. History of brain surgery

2. Seizures during the previous 12 months

3. Sensitive scalp (per patient report)

4. Able to overtly name more than an average of 140 out of 175 items during the
pre-treatment picture naming test (Philadelphia Naming Test) during Visits 2 or 3.

5. Unable to overtly name at least an average of 5 out of 80 items during the
pre-treatment fMRI sessions during Visits 2 or 3.
We found this trial at
2
sites
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Principal Investigator: Julius Fridriksson, PhD
Phone: 843-792-2845
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Columbia, South Carolina 29208
Phone: 803-777-2693
?
mi
from
Columbia, SC
Click here to add this to my saved trials